Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1340422
European Journal of Endocrinology, Vol 134, Issue 4, 422-423
Copyright © 1996 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dutour, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dutour, A.

Dichlorodiphenyltrichloroethane and androgen receptor

Anne Dutour

A recent paper from William Kelce et al. (Nature, 1995; 375:581–585) points out that the major metabolite of dichlorodiphenyltrichloroethane (DDT), 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (p,p'DDE), is a potent androgen receptor antagonist and can damage male reproduction. According to the authors, DDT and its major metabolite could be one of the factors responsible for the increasing male tract abnormalities reported in humans and animals. Indeed, various recent studies have reported an increased incidence of hypospadias and cryptorchidism and an increased incidence of testicular cancer (1). A recent study has shown that during the past 20 years there has been a decline in the concentration and motility of sperm and in the percentage of normal spermatozoa in fertile men in the Paris region (2). It has been hypothesized that all these changes have a common origin and may be related to environmental exposure or to a change in life style which has







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 European Society of Endocrinology.